Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Congenital Cytomegalovirus Infection
100%
Cytomegalovirus
85%
Hearing Impairment
46%
Gestational Diabetes
39%
Infection
36%
Cesarean Section
35%
First Trimester Pregnancy
31%
Cytomegalovirus Infection
31%
Amniocentesis
30%
Pelvis
30%
Neonate
27%
Second Trimester Pregnancy
25%
Vascular Disease
24%
Postmenopause
22%
Pregnant Woman
21%
Diseases
21%
Gestational Age
21%
Hearing
21%
Retrospective Cohort Study
20%
Third Trimester Pregnancy
20%
Valaciclovir
19%
Hyperemesis Gravidarum
19%
Central Nervous System
18%
Glucose
17%
Antiviral Therapy
17%
Pre-Eclampsia
17%
Odds Ratio
16%
Vaginal Delivery
16%
Valganciclovir
15%
Placebo
13%
Primary Infection
13%
Vertical Transmission
13%
Case-Control Study
11%
Oligohydramnios
11%
Endometrium
11%
Microbiome
11%
Congenital Infection
10%
Adverse Event
10%
Biochemical Marker
10%
Bladder
10%
Amnion Fluid
10%
Evoked Brain Stem Response
9%
Deterioration
9%
Hyperglycemia
9%
Vaginal Ultrasonography
9%
Placenta Development
9%
Neutropenia
9%
Triple Test
9%
Gingivostomatitis
9%
Human Alphaherpesvirus 1
9%
Keyphrases
Cytomegalovirus Infection
90%
Pregnancy Outcome
52%
During Pregnancy
49%
Congenital Cytomegalovirus (cCMV)
43%
Pregnant Women
38%
Gestational Diabetes Mellitus
36%
Hearing Impairment
33%
Cytomegalovirus
30%
Single-center Experience
28%
Amniocentesis
26%
Vasculopathy
24%
First Trimester
20%
Week of Gestation
20%
Isolated Oligohydramnios
19%
Aciclovir
19%
Gestational Diabetes
19%
Birth Beliefs
19%
Infections In Pregnancy
18%
Gestational Age
18%
At Birth
18%
Antiviral Treatment
16%
Second Trimester
16%
Postmenopausal Women
16%
Biochemical Markers
14%
Neonatal Outcomes
14%
Perinatal Outcome
14%
Vertical Transmission
13%
High-risk Women
13%
High Risk
13%
Triple Test
12%
Infertility
12%
Israeli
12%
Second Trimester of Pregnancy
12%
Maternal Primary Infection
12%
Age at First Birth
12%
Beliefs about Birth
12%
Late-onset Hearing Loss
12%
Birth Experience
12%
Neonate
11%
Glycemic Control
11%
Retrospective Cohort Study
11%
Preeclampsia
11%
34 Weeks of Gestation
11%
Singleton Pregnancy
11%
Human Chorionic Gonadotropin
10%
Randomized Placebo-controlled Trial
10%
Retrospective Case Series
10%
Congenital Infection
10%
Third Trimester
10%
Brain Ultrasound
10%
